Skip Nav Destination
Issues
1 November 2002
ISSN 1055-9965
EISSN 1538-7755
Hypothesis
Research Articles
Prostaglandin H Synthase 2 Variant (Val511Ala) in African Americans May Reduce the Risk for Colorectal Neoplasia1
Henry J. Lin; Karen M. Lakkides; Temitope O. Keku; Srinivasa T. Reddy; Andrew D. Louie; Irving H. Kau; Haiyan Zhou; Jason S. Y. Gim; Hoang L. Ma; Carl F. Matthies; Aihua Dai; Hsiao-Fen Huang; Alicia M. Materi; Jesse H. Lin; Harold D. Frankl; Eric R. Lee; Steven I. Hardy; Harvey R. Herschman; Brian E. Henderson; Laurence N. Kolonel; Loïc Le Marchand; R. Michael Garavito; Robert S. Sandler; Robert W. Haile; William L. Smith
p53 Mutations in L3-Loop Zinc-binding Domain, DNA-Ploidy, and S Phase Fraction Are Independent Prognostic Indicators in Colorectal Cancer: A Prospective Study with a Five-Year Follow-Up1
Antonio Russo; Manuela Migliavacca; Ines Zanna; Maria Rosaria Valerio; Mario Adelfio Latteri; Nello Grassi; Gianni Pantuso; Sergio Salerno; Gabriella Dardanoni; Ida Albanese; Mario La Farina; Rosa Maria Tomasino; Nicola Gebbia; Viviana Bazan
Differences in KRAS Mutation Spectrum in Lung Cancer Cases between African Americans and Caucasians after Occupational or Environmental Exposure to Known Carcinogens1
Jay D. Hunt; Anna Strimas; Julie E. Martin; Marilyn Eyer; Monica Haddican; Brian G. Luckett; Bernardo Ruiz; T. William Axelrad; Wayne L. Backes; Elizabeth T. H. Fontham
Influence of Selenium-enriched Yeast Supplementation on Biomarkers of Oxidative Damage and Hormone Status in Healthy Adult Males: A Clinical Pilot Study1
Karam El-Bayoumy; John P. Richie, Jr.; Telih Boyiri; Despina Komninou; Bogdan Prokopczyk; Neil Trushin; Wayne Kleinman; Julie Cox; Brian Pittman; Steven Colosimo
Short Communications
Null Results in Brief
Correction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.